Sefer Gezer to Bone Marrow
This is a "connection" page, showing publications Sefer Gezer has written about Bone Marrow.
Connection Strength
0.208
-
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol. 1999 Feb; 62(2):90-4.
Score: 0.039
-
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996 Nov-Dec; 20(11-12):891-900.
Score: 0.033
-
Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996 Oct 01; 88(7):2640-7.
Score: 0.033
-
Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995 Jul 01; 86(1):268-76.
Score: 0.030
-
Expression of nucleolar antigen p145 in bone marrow cells of patients with myeloid leukemias. Cancer Res. 1989 Jan 15; 49(2):482-7.
Score: 0.019
-
Detection of BrdU in the regenerating bone marrow cells of a patient with AML. Leuk Res. 1989; 13(12):1055-9.
Score: 0.019
-
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood. 2001 Aug 15; 98(4):958-65.
Score: 0.012
-
A paradigm shift in myelodysplastic syndromes. Leukemia. 1996 Oct; 10(10):1648-52.
Score: 0.008
-
Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol. 1996 Jun; 63(4):265-78.
Score: 0.008
-
Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Exp Hematol. 1992 Nov; 20(10):1194-200.
Score: 0.006